Symbol: |
BTBD16
|
Description: |
BTB (POZ) domain containing 16 [Source:HGNC Symbol;Acc:26340]
|
Location: |
Chr10:124030821-124097677[+]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:155
Gene |
Compound |
Gen_sig |
Exp_pattern |
BTBD16 |
NSC 721875 |
0.014 |
Down |
BTBD16 |
NSC 722876 |
0.047 |
Down |
BTBD16 |
(Thiopen-2-ylmethylene-hydrazinocarbonylmethylsulfanyl) acetic acid(thiopen-2-ylmethylene)-hydrazide |
0.001 |
Up |
BTBD16 |
4,11-dihydroxy-1-[4-(4-hydroxy-1-piperidinyl)butyl]-1H-napht ho[2,3-f]indole-5,10-dione |
0.012 |
Down |
BTBD16 |
1, 1'[Pentane-1,5-diyl)dioxy]bis(11as)-2-fluoro-7-methoxy-1,2,3 ,11a-tetrahydro-5H-pyrrolo[2,1-c][1,4]benzodiazepin-5-one |
0.043 |
Up |
BTBD16 |
Everolimus |
0.014 |
Up |
BTBD16 |
4-[(Z)-2-(5-nitro-2-furyl)ethenyl]-6-(4-phenylpiperazin-1-yl )-1,3,5-triazin-2-ylamine |
0.035 |
Down |
BTBD16 |
4-[(Z)-2-phenylethenyl]-6-(3,5,5-trimethyl-4,5-dihydro-1H-py razol-1-yl)-1,3,5-triazin-2-ylamine |
0.008 |
Down |
BTBD16 |
NSC 736149 |
0.009 |
Up |
BTBD16 |
NSC 736189 |
0.037 |
Up |
BTBD16 |
NSC 737745 |
0.044 |
Up |
BTBD16 |
6-(3-fluoro-4-methoxyphenyl)-5-(3,4,5-trimethoxyphenyl)-2H-pyran-2-one |
0.01 |
Down |
BTBD16 |
12-Benzyl-5,12-dihydro-indeno[2',1':4,5]pyrrolo[3,2-c]chinolin-6,7-dione |
0.008 |
Up |
BTBD16 |
1,7-bis(6-methoxybenzothizol-2-yl)aminoacetyloxy)-3-ethoxyphenyl)-1,7-heptadien-3,5-dione |
0.033 |
Down |
BTBD16 |
4-(m-Fluorobenzylidene)-2-phenyl-2-oxazolin-5-one |
0.01 |
Up |
Expression pattern: Sensitivity / Resistance
Total:11 Current:10
First Prev Next Last 
|
SNP:
~ Export ~
|
Records:2
SNP |
Gene |
SNP_location |
SNP_allele |
rs186844859 |
BTBD16 |
Chr10:124097627 |
T/C |
rs200647266 |
BTBD16 |
Chr10:124097635 |
A/G |
Total:1 Current:1
[First] [Prev] [Next] [Last]
|
miRNA:
~ Export ~
|
Records:28
Total:2 Current:1
[First] [Prev]  Next Last 
|